ANARIDEX 1 is a pharmaceutical-grade Anastrozole 1 mg tablet specifically formulated for treating hormone receptor-positive breast cancer in postmenopausal women. As a potent non-steroidal aromatase inhibitor, ANARIDEX 1 effectively lowers estrogen levels, thereby slowing or halting the progression of estrogen-sensitive tumors. Manufactured under the Dr Precision label with WHO-GMP compliance, this high-quality medicine meets stringent international standards for safety and efficacy. ANARIDEX 1 is commonly used as a first-line therapy as well as an adjuvant treatment post-surgery or radiation. Represented by BLUEPILL EXPRESS, a global pharmaceutical exporter and third-party manufacturer, ANARIDEX 1 is ideal for bulk supply and private labeling, making it a reliable product for distributors in regulated and semi-regulated markets worldwide.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Anastrozole 1 mg |
| Therapeutic Use | Treatment of hormone receptor-positive breast cancer in postmenopausal women |
| Mechanism of Action | Aromatase inhibitor that reduces estrogen production |
| Dosage Form | Oral tablet |
| Manufacturer | Dr Precision |
| Certification | WHO-GMP certified manufacturing |
| Export Representation | BLUEPILL EXPRESS |
| Compliance | Meets international pharmaceutical standards |
| Usage Stage | First-line and adjuvant treatment |
| Packaging | Suitable for bulk supply and private labeling |
| Attributes | Description |
|---|---|
| Strength | 1 mg per tablet |
| Formulation Type | Non-steroidal aromatase inhibitor |
| Indication | Hormone receptor-positive breast cancer |
| Target Patient Group | Postmenopausal women |
| Storage Conditions | Store below 25°C, in a dry place away from light |
| Shelf Life | As per manufacturing batch, typically 2 years |
| Regulatory Compliance | WHO-GMP certified, suitable for international export |
| Manufacturer Location | Produced under Dr Precision label |
| Export Markets | Regulated and semi-regulated international markets |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
ANARIDEX 1 is specifically formulated and prescribed for postmenopausal women with hormone receptor-positive breast cancer and is generally not recommended for premenopausal patients without additional hormonal suppression therapy.
Yes, ANARIDEX 1 is frequently prescribed as part of adjuvant treatment following surgery or radiation therapy to help reduce the risk of cancer recurrence by lowering estrogen levels.
ANARIDEX 1 is manufactured under WHO-GMP certified facilities by Dr Precision, ensuring adherence to strict quality, safety, and regulatory guidelines suitable for both regulated and semi-regulated markets.
Yes, ANARIDEX 1 is offered by BLUEPILL EXPRESS for bulk supply and supports private labeling options, making it ideal for distributors and pharmaceutical companies targeting international markets.
By inhibiting the aromatase enzyme, ANARIDEX 1 effectively lowers estrogen production in the body, which is vital in slowing or stopping the growth of estrogen-sensitive tumors.
Country Of Origin: India
ANARIDEX 1 is a highly effective Anastrozole 1 mg tablet used for the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works as an aromatase inhibitor, reducing estrogen levels to slow or stop tumor growth. Represented by BLUEPILL EXPRESS, a global exporter of all types of medicines, ANARIDEX 1 meets international pharmaceutical standards for safety, efficacy, and compliance.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
ANARIDEX 1 contains Anastrozole 1 mg, a potent non-steroidal aromatase inhibitor that is primarily prescribed for the treatment of hormone receptor-positive breast cancer in postmenopausal women. Estrogen can promote the growth of certain types of breast tumors, and Anastrozole works by inhibiting the enzyme aromatase, which is involved in the production of estrogen.
By significantly lowering estrogen levels in the body, ANARIDEX 1 slows down or prevents the growth of estrogen-sensitive tumors. It is often used as a first-line treatment, and may also be prescribed following surgery or radiation therapy as part of an adjuvant treatment plan.
BLUEPILL EXPRESS, a trusted name in global pharmaceutical exports and third-party manufacturing, proudly represents ANARIDEX 1. With WHO-GMP-certified production facilities and strict regulatory compliance, the product is suitable for bulk supply, private labeling, and international export to regulated and semi-regulated markets.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
